Author:
Singer A.,McClung M. R.,Tran O.,Morrow C. D.,Goldstein S.,Kagan R.,McDermott M.,Yehoshua A.
Abstract
Abstract
Summary
In a characterization of treatment rates and healthcare costs among patients with an osteoporotic-related fragility fracture overall and by site of care, costs were high and treatment rates were low.
Purpose
Osteoporotic fractures can be debilitating, even fatal, among older adults. The cost of osteoporosis and related fractures is projected to increase to more than $25 billion by 2025. The objective of this analysis is to characterize disease-related treatment rates and healthcare costs of patients with an osteoporotic fragility fracture overall and by site of fracture diagnosis.
Methods
In this retrospective analysis, individuals with fragility fractures were identified in the Merative MarketScan® Commercial and Medicare Databases among women 50 years of age or older and diagnosed with fragility fracture between 1/1/2013 and 6/30/2018 (earliest fracture diagnosis = index). Cohorts were categorized by clinical site of care where the diagnosis of fragility fracture was made and were continuously followed for 12 months prior to and following index. Sites of care were inpatient admission, outpatient office, outpatient hospital, emergency room hospital, and urgent care.
Results
Of the 108,965 eligible patients with fragility fracture (mean age 68.8), most were diagnosed during an inpatient admission or outpatient office visit (42.7%, 31.9%). The mean annual healthcare costs among patients with fragility fracture were $44,311 (± $67,427) and were highest for those diagnosed in an inpatient setting ($71,561 ± $84,072). Compared with other sites of care at fracture diagnosis, patients diagnosed during an inpatient admission also had highest proportion of subsequent fractures (33.2%), osteoporosis diagnosis (27.7%), and osteoporosis therapy (17.2%) during follow-up.
Conclusion
The site of care for diagnosis of fragility fracture affects treatment rates and healthcare costs. Further studies are needed to determine how attitude or knowledge about osteoporosis treatment or healthcare experiences differ at various clinical sites of care in the medical management of osteoporosis.
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine
Reference31 articles.
1. Tella SH, Gallagher JC (2014) Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol 142:155–170
2. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. The Lancet 359(9319):1761–1767
3. International Osteoporosis Foundation (2018) Broken bones, broken lives: a roadmap to solve the fragility fracture crisis in Europe. 2018; https://www.osteoporosis.foundation/educational-hub/files/broken-bones-broken-lives-roadmap-solve-fragility-fracture-crisis-europe.
4. Cauley JA, Wampler NS, Barnhart JM et al (2008) Incidence of fractures compared to cardiovascular disease and breast cancer: the Women’s Health Initiative Observational Study. Osteoporos Int 19(12):1717–1723
5. Bone Health & Osteoporosis Foundation (2022) What is osteoporosis and what causes it?; https://www.bonehealthandosteoporosis.org/patients/what-is-osteoporosis/.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献